Results at month 7 of CABO-CHANCE study: real-world evidence (RWE) on the use of intramuscular cabotegravir plus rilpivirine long-acting (CAB plus RPV LA) dosed every 2 months in viral suppressed people with HIV (PWH)

被引：0

作者：

Tenorio, Carmen Hidalgo ^{[1
]}

Aguilera-Garcia, Maria ^{[2
]}

Santos, Ignacio De Los ^{[2
]}

Vinuesa, David ^{[3
]}

Omar, Mohamed ^{[4
]}

Lirola, Ana Lopez ^{[5
]}

Bernal, Enrique ^{[6
]}

Martinez, Onofre Juan ^{[7
]}

Romero, Alberto ^{[8
]}

Sorni, Patricia ^{[9
]}

Lopez, Teresa ^{[10
]}

Cardenas, Salvador Lopez ^{[11
]}

Moreno, Santiago ^{[12
]}

Conde, Isabel San Joaquin ^{[13
]}

Blanco, Jose Ramon ^{[14
]}

Garcia-Vallecillos, Coral ^{[1
]}

机构：

[1] Hosp Univ Virgen Ias Nieves, Infect Dis, Granada, Spain

[2] Hosp Univ Princesa, Infect Dis, Madrid, Spain

[3] Hosp Univ San Cecilio, Infect Dis, Granada, Spain

[4] Complejo Hospitalario Jaen, Infect Dis, Jaen, Spain

[5] Hosp Univ Canarias, Infect Dis, San Cristobal la Laguna, Spain

[6] Hosp Univ Reina Sofia, Infect Dis, Murcia, Spain

[7] Hosp Santa Lucia, Cartajena, Spain

[8] Hosp Univ Puerto Real, Infect Dis, Cadiz, Spain

[9] Hosp Univ Son Llatzer, Infect Dis, Palma de Mallorca, Spain

[10] Hosp Santa Ana, Internal Med, Motril, Spain

[11] Hosp Univ Jerez, Infect Dis, Cadiz, Spain

[12] Hosp Univ Ramon & Cajal, Infect Dis, Madrid, Spain

[13] Hosp Univ Lozano Blesa, Infect Dis, Zaragoza, Spain

[14] Hosp Univ San Pedro, Infect Dis, Logrono, Spain

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

P096

引用

页码：108 / 109

页数：2